Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier for advanced OPTIONS screeners and volatility tools. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

CVS Corp (CVS)

CVS Corp (CVS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 82,809,024
  • Shares Outstanding, K 1,260,795
  • Annual Sales, $ 372,809 M
  • Annual Income, $ 4,614 M
  • EBIT $ 8,516 M
  • EBITDA $ 13,113 M
  • 60-Month Beta 0.54
  • Price/Sales 0.22
  • Price/Cash Flow 7.24
  • Price/Book 1.09

Options Overview Details

View History
  • Implied Volatility 32.15% ( -2.85%)
  • Historical Volatility 46.73%
  • IV Percentile 54%
  • IV Rank 37.82%
  • IV High 51.06% on 08/05/24
  • IV Low 20.64% on 05/17/24
  • Put/Call Vol Ratio 0.42
  • Today's Volume 54,045
  • Volume Avg (30-Day) 28,928
  • Put/Call OI Ratio 0.96
  • Today's Open Interest 780,286
  • Open Int (30-Day) 777,844

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 23 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/25
See More
  • Average Estimate 1.62
  • Number of Estimates 11
  • High Estimate 1.87
  • Low Estimate 1.28
  • Prior Year 1.31
  • Growth Rate Est. (year over year) +23.66%

Price Performance

See More
Period Period Low Period High Performance
1-Month
62.02 +5.90%
on 02/21/25
67.25 -2.33%
on 03/14/25
-0.15 (-0.23%)
since 02/14/25
3-Month
43.56 +50.78%
on 12/23/24
67.34 -2.47%
on 02/13/25
+16.31 (+33.04%)
since 12/13/24
52-Week
43.56 +50.78%
on 12/23/24
80.75 -18.66%
on 03/28/24
-10.74 (-14.05%)
since 03/14/24

Most Recent Stories

More News
Is Humana Stock Underperforming the Nasdaq?

Although Humana has underperformed relative to the broader Nasdaq Composite over the past year, Wall Street analysts maintain a moderately optimistic outlook on the stock’s prospects.

HUM : 252.88 (+0.46%)
CVS : 65.68 (-0.11%)
$NASX : 17,754.09 (+2.61%)
These 3 Dividend Stocks Jumped 15% in a Month—More to Come?

Dividend stocks aren't just for long-term income generation. These three shares have jumped 15% in one month while also offering dividend payouts.

CVS : 65.68 (-0.11%)
VZ : 43.57 (-0.32%)
GILD : 111.44 (-1.69%)
Walgreens Boots Alliance: Don’t Write Off This Asset Champ Yet

Walgreens Boots Alliance agreed to an $11.45 per share buyout by Sycamore Partners, but shareholders can reject the deal and holdout for a better offer.

CVS : 65.68 (-0.11%)
WBA : 11.23 (-0.27%)
CVS Health (CVS): Buy, Sell, or Hold Post Q4 Earnings?

CVS Health (CVS): Buy, Sell, or Hold Post Q4 Earnings?

CVS : 65.68 (-0.11%)
NET : 116.15 (+2.15%)
ReShape Lifesciences, Allarity, Exact Sciences, CVS, AbbVie: 5 Health Care Stocks That Led Retail Message Growth Last Week

Speculation over an impending reverse merger, a Phase 2 trial announcement, comments about upcoming cancer screening tests, a Medicare business deal, and an obesity drug partnership sparked buzz among...

CVS : 65.68 (-0.11%)
EXAS : 45.00 (+4.55%)
ABBV : 211.77 (+0.10%)
RSLS : 0.6355 (+0.08%)
ALLR : 0.9586 (+6.17%)
3 Dividend Stocks To Buy and Survive a Market Crash

Defensive sectors like consumer staples, healthcare, and utilities offer stability during downturns. Three top-rated picks were identified for their resilience, high yields, and growth potential.

CVS : 65.68 (-0.11%)
KO : 69.16 (+0.07%)
BEP : 22.75 (-0.26%)
Is CVS Health Stock Outperforming the S&P 500?

CVS Health has outperformed the broader S&P Index’s performance over the past year, and analysts remain strongly upbeat about the stock’s prospects.

CVS : 65.68 (-0.11%)
$SPX : 5,638.94 (+2.13%)
CI : 312.90 (+0.29%)
Walgreens agrees to be acquired by private equity firm for almost $10 billion

Walgreens Boots Alliance says it has agreed to be acquired by the private equity firm Sycamore Partners as the struggling retailer looks to turn itself around after years of losing money

CVS : 65.68 (-0.11%)
$SPX : 5,638.94 (+2.13%)
WBA : 11.23 (-0.27%)
KR : 65.10 (-1.51%)
COR : 258.07 (+0.80%)
$DOWI : 41,488.19 (+1.65%)
$IUXX : 19,704.64 (+2.49%)
Analysts Are Pounding the Table: Sell This High-Yield Dividend Stock Now

Walgreens Boots Alliance, once a reliable dividend stock, is now under scrutiny as it suspends dividend payments, faces declining retail performance, and navigates potential takeover talks.

CVS : 65.68 (-0.11%)
DG : 79.02 (-1.16%)
WBA : 11.23 (-0.27%)
AMZN : 197.95 (+2.09%)
Worried About the Stock Market? Put Your Money Into This Value-Focused ETF

Invesco S&P 500 Pure Value ETF (NYSE Arca:RPV) offers investors a targeted way to access some of ...

CVS : 65.68 (-0.11%)
F : 9.73 (+2.10%)
RPV : 90.77 (+1.54%)
TSN : 59.88 (-0.20%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Buy with a Strengthening short term outlook on maintaining the current direction.

See More Share

Business Summary

CVS Health Corporation is a pharmacy innovation company. Its offerings include pharmacy benefit management services, mail order, retail and specialty pharmacy, disease management programs, and retail clinics. The Company serves employers, insurance companies, unions, government employee groups, managed...

See More

Key Turning Points

3rd Resistance Point 68.59
2nd Resistance Point 67.92
1st Resistance Point 66.80
Last Price 65.68
1st Support Level 65.01
2nd Support Level 64.34
3rd Support Level 63.22

See More

52-Week High 80.75
Fibonacci 61.8% 66.54
Last Price 65.68
Fibonacci 50% 62.15
Fibonacci 38.2% 57.77
52-Week Low 43.56

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar